Endo initiated the financial restructuring process after reaching an agreement with a group of its senior debtholders on a transaction that would substantially reduce outstanding debt, address remaining opioid and other litigation-related claims, and best position Endo for the future. This will allow the Company to advance its ongoing business transformation from a strengthened financial position to create compelling value for its stakeholders over the long term.

Endo's day-to-day operations, ordinary course investments, collaborative engagement with customers and partners, and focus on its mission will continue as usual – without interruption.

Endo's India-based entities are not part of the Chapter 11 proceedings. The Company expects to file recognition proceedings in Canada, the United Kingdom, and Australia.

‍